Faculty Bibliography

BACKGROUND CONTEXT: Few studies investigate segmental lordosis restoration after long fusion with anterior (ALIF) vs transforaminal lumbar interbody fusion (TLIF) for adults with flatback deformity. PURPOSE: Our objective was to compare segmental lordosis restoration, health-related quality-of-life (HRQL), and complications associated with L4-S1 ALIF vs TLIF in operative treatment of flatback deformity. STUDY DESIGN/SETTING: Retrospective review of a prospectively collected multicenter consecutive case registry. PATIENT SAMPLE: Database enrollment required age >=18 years, scoliosis >=20degree, sagittal vertical axis (SVA) >=5cm, pelvic tilt >=25degree, or thoracic kyphosis >=60degree. OUTCOME MEASURES: Radiographic correction (including L4-S1 segmental lordosis), HRQL (Oswestry Disability Index [ODI], Short Form-36 [SF-36] scores, Scoliosis Research Society-22 [SRS-22r] scores), and complications.
Method(s): Prospective multicenter data were reviewed. Study inclusion required pelvic incidence to lumbar lordosis mismatch >=10degree (flatback), index ALIF vs TLIF at L4-L5 and/or L5-S1, and minimum 2-year follow-up. Cage details (height and lordosis) were also assessed.
Result(s): Of 222 consecutive patients, 157 (71%) achieved 2-year follow-up (age=63+/-10years, women=82%, ALIF=43%, TLIF=57%). Index operations had 12+/-3 posterior levels, iliac fixation=93%, and ALIF/TLIF at L4-L5 (66%) and L5-S1 (85%). ALIF vs TLIF cages were similar in height, but cage lordosis was greater for ALIF: L4-L5 (9degree+/-5degree vs 7degree+/-2degree, p=0.025) and L5-S1 (14degree+/-9degree vs 7degree+/-3degree, p<0.001). ALIF (vs TLIF) was associated with significantly more L4-S1 segmental lordosis at last follow-up (37degree+/-11degree vs 31degree+/-9degree, p<0.001) despite similar baseline measurement (32degree+/-15degree vs 31degree+/-14degree, p=0.705). Multiple regression demonstrated 1degree increase in L4-L5 ALIF cage lordosis led to 0.9degree increase in L4-L5 segmental lordosis (p=0.014), and 1degree increase in L5-S1 ALIF cage lordosis led to 0.5degree increase in L5-S1 segmental lordosis (p=0.005). For all patients, final alignment improved significantly (p<0.05): T12-S1 lordosis (25degree+/-17degree to 48degree+/-13degree), L4-S1 lordosis (32degree+/-14degree to 34degree+/-10degree),

BACKGROUND CONTEXT: Cervical deformity (CD) surgery can markedly improve patient quality of life. The longevity of CD correction and the mechanism of alignment deterioration are not well understood. PURPOSE: To investigate preoperative risk factors and failure mechanisms that erode CD corrections and the impact on functional outcomes. STUDY DESIGN/SETTING: Retrospective review of a prospective CD database. PATIENT SAMPLE: This study included 155 operative CD patients with baseline (BL) and 1-year follow-up. OUTCOME MEASURES: Alignment at baseline, 3 months, 6 months and 1 year: cervical sagittal vertical axis (cSVA), C2 Slope (C2S), T1 slope (T1S), C2-C7 lordosis (CL), T1S-CL mismatch (TS-CL), Neck Disability Index (NDI), Modified Japanese Orthopaedic Association score (mJOA).
Method(s): A retrospective review of a prospective database of operative CD patients was analyzed. Patients with baseline, 3-month, 6-month and 1-year cervical radiographs were included. Cervical sagittal vertical axis (cSVA) <4cm was used to categorize patients as well-aligned vs malaligned. Additionally, three subsets were defined as follows: (1) patients who were malaligned preoperatively (cSVA>=4) and remained well aligned at 1 year postoperatively; (2) patients who were well-aligned but experienced alignment deterioration (cSVA>=4cm) up to 1 year postop, and; (3) patients who never attained cSVA <4cm. These groups were compared in terms of demographic factors, surgical factors, baseline radiographic parameters and radiographic and surgical outcomes at baseline and 1 year, using t-tests and X2 tests for continuous and categorical variables, respectively.
Result(s): A total of 155 patients were included (mean age 61.41, 60.9% F). The entire cohort was analyzed at all time points for alignment using cSVA. Among 89 patients with X-rays at every time point, 30 patients (34%) maintained their good alignment correction at 1-year postop. Seventeen patients (19%) experienced alignment deterioration and 42 patients (46%) never reached cSVA <4cm at any time point. Four patients lost their correction at 3 months, 6 patients at 6 months and 8 patients were malaligned by 1 year. The never-aligned cohort was significantly older when compared to those who maintained alignment or those who deteriorated (65.9 vs 61.8 vs 58.8, p=0.038). Patients who never achieved good alignment and those who suffered deterioration had a significantly higher rate of DJK (42.9% vs 47.1% vs 3.3%, p=0.001). Other failure mechanisms in the deterioration group included loss of subjacent spinopelvic compensation and PJK. At baseline, patients with alignment deterioration had a smaller cSVA compared to those who maintained or never reached good alignment (40.5 vs 52.0 and 60.1mm, p=0.001), and less TK (-43.4 vs -55.9 vs -61.4, p=0.049). At 1-year postop, patients with deterioration had worsening of their mJOA score at 6 months compared to those who maintained or never reached proper alignment (2.50 vs 0.04 vs 1.20, p=0.032). There were no significant differences in smokers, BMI, frailty, osteoporosis, levels fused, UIV, LIV, EBL, operative time, rod diameter, rod material, utilization 3-column osteotomy, mean osteotomy grade, in construct (fused) loss of alignment or revision rate between the groups (all p>.05)
Conclusion(s): Cervical deformity correction surgery failed to achieve acceptable sagittal alignment in 46% of patients. In those with successful correction, 36% suffered alignment deterioration within 1 year. Distal junctional kyphosis was the most common failure mechanism leading to loss of correction. FDA DEVICE/DRUG STATUS: This abstract does not discuss or include any applicable devices or drugs.
Copyright

BACKGROUND CONTEXT: Both frailty and surgical invasiveness are correlated with increased risk of complications following ASD surgery, yet there is no accepted risk-stratification system combining these factors. PURPOSE: The aim of this study is to ascertain data-driven categories defining the risk for 90-day complications following ASD surgery based on frailty and surgical invasiveness. STUDY DESIGN/SETTING: Retrospective review of a multicenter database. PATIENT SAMPLE: A total of 1,272 surgical ASD patients undergoing spinal fusions >=5 levels OUTCOME MEASURES: Ninety-day complication risk, 90-day complication rate, invasiveness thresholds for increased complications.
METHOD(S): Using a prospective, multicenter database, we identified 1,272 surgical ASD patients undergoing posterior spinal fusion of at least five levels. Patients were separated into three frailty groups based on the ASD-FI frailty index. Within each frailty group, stratum-specific likelihood ratio (SSLR) analyses were performed to define frailty-based surgical invasiveness cutoffs associated with increased risk for 90-day complications. Cutoffs generated through SSLR were confirmed with multivariable logistic regression analysis controlling for age, alignment, and ODI.
RESULT(S): Mean age was 60 +/- 14 years, 74% females. Of 1,272 surgical ASD patients, 319 (35%) were nonfrail (NF), 667 (52%) frail (F), and 286 (23%) severely frail (SF). Mean SI was 93 +/- 35. The mean complication rate was 35.4% for NF, 37% for F and 43.6% for SF. SSLR analysis of NF patients produced 2 complication categories: 33% complication rate for SI < 153 and 73% for SI >= 153. NF patients with SI >= 153 had 4.14x higher odds of complications than NF patients with SI <153 (p=0.04). SSLR analysis of F patients produced 3 complication categories: 26% complication rate for SI < 60, 42% for SI of 60 to 179, and 64% for SI >= 180. Relative to F patients with SI < 60, F patients with SI 60 to 179, and SI >= 180 had 2.4x and 6.7x higher odds of complications, respectively (p<0.01 for both). SSLR analysis of SF patients produced 2 complication categories: 35% complication rate for SI < 82 and 49% complication rate for SI >= 82. SF patients with SI >= 82 had 1.77x higher odds of complications than SF patients with SI < 82 (p=0.04).
CONCLUSION(S): Frailer groups were found to have lower SI cutoffs, indicating the less invasiveness surgeries can be performed on frail patients to minimize complication risk. This risk-stratification system is useful for counselling patients regarding their risk of complication. FDA DEVICE/DRUG STATUS: This abstract does not discuss or include any applicable devices or drugs.
Copyright

BACKGROUND CONTEXT: Concerns exist regarding disease transmission and cost associated with postoperative nonroutine discharge. Few data exist evaluating impact of nonroutine vs home discharge on readmissions, complications and patient reported outcome measures (PROMs) for adult spinal deformity (ASD) surgery. PURPOSE: Evaluate 30-day readmissions, 90-day return to surgery, postoperative complications, and postoperative PROMs for matched ASD patients receiving nonroutine discharge vs home discharge following surgery. STUDY DESIGN/SETTING: Propensity score matched (PSM) analysis of ASD patients prospectively enrolled into a multicenter study. PATIENT SAMPLE: Surgically treated ASD patients prospectively enrolled into multicenter study. OUTCOME MEASURES: Numeric rating scale (NRS) back and leg pain, Scoliosis Research Society-22r questionnaire (SRS-22r), Short Form-36v2 questionnaire (SF-36), Oswestry Disability Index (ODI), duration of hospital stay, 30-day readmission, 90-day return to surgery, postoperative complications.
METHOD(S): Surgically treated ASD patients prospectively enrolled in a multicenter ASD study were divided into two discharge disposition groups, nonroutine (NON) and home (HOME). NON was further divided into acute rehab (REHAB) or skilled nursing facility (SNF) discharge. Study inclusion criteria; (1) surgery >=5 levels fused, (2) >=2-year follow-up. PSM was used to match NON vs HOME for age, frailty and total levels fused. 30-day hospital readmission, 90-day return to surgery, postoperative complications, one and minimum 2 year PROM data was compared for NON vs HOME, and REHAB vs SNF vs HOME.
RESULT(S): From 2015 to 2019, 241 of 374 eligible treated patients were evaluated and 158 included in this study after PSM (mean 2.7 year follow-up). NON (n=106) and HOME (n=52) had similar age (67.6 vs 67.6 years), ASD-frailty index (3.9 vs 3.9), levels fused at surgery (13.8 vs 13.7), and preop PROMs, respectively (p>0.05). Duration of hospital stay (9.7 vs 10.4 days), 30-day readmission (6.6% vs 6.6%), 90-day return to surgery (9.4% vs10.4%), total complications/patient (2.0 vs 1.5), major complications/patient (0.8 vs 0.5), were similar NON vs HOME, respectively (p>0.05). At last follow-up, HOME demonstrated better ODI (21.6 vs 28.2), SRS-total (3.8 vs 3.5), and SRS-activity (3.7 vs 3.3) than NON, respectively (p<0.05). Sub-analysis of REHAB (N=63) vs SNF (N=41) vs HOME showed similar findings, including similar 30-day readmissions, 90-day return to surgery, and complications (p>0.05) and improved PROMs for HOME vs REHAB and SNF (p<0.05).
CONCLUSION(S): Analysis of 158 operatively treated ASD patients prospectively enrolled into a multicenter study and matched for age, frailty, and surgery performed demonstrated that postoperative discharge to skilled nursing or acute rehab facilities did not reduce 30-day readmissions, 90-day return to surgery, or postoperative complications. At one and minimum two years postop, patients discharged home had better PROMs scores than nonroutine discharge. These data should be considered in conjunction with postoperative needs and the cost and disease transmission risks for nonroutine discharge. FDA DEVICE/DRUG STATUS: This abstract does not discuss or include any applicable devices or drugs.
Copyright

BACKGROUND CONTEXT/BACKGROUND:In 2008, the Centers for Medicare and Medicaid Services (CMS) established a list of hospital-acquired conditions (HACs) with significant deleterious effects on both patients and providers. Adult spinal deformity (ASD) surgery is complex and highly invasive, and as such may result in significant morbidity including these HACs. PURPOSE/OBJECTIVE:Identify predictors for developing the most common HACs among adult spinal deformity(ASD) patients undergoing corrective surgery. STUDY DESIGN/SETTING/METHODS:Retrospective analysis PATIENT SAMPLE: 1,171 ASD patients OUTCOME MEASURES: HACs, Health-Related Quality of Life scores(HRQLs), Reoperation, Integrated Health State (IHS) METHODS: ASD pts undergoing surgery (>18yrs, scoliosis ≥20°, SVA≥5cm, PT≥25° and/or TK >60°) with complete data at BL and up to 2 years post-op were included. Patients were stratified by presence of >1 HAC, defined as at least one superficial/deep SSI, UTI, DVT, or PE within a 30-day post-op window. Random forest analysis generated 5,000 Conditional Inference Trees to compute a variable importance table for top predictors of HACs. An area-under-the-curve (AUC) methodology compared normalized HRQL scores between groups to determine an IHS with 2-year follow-up. RESULTS:1,171 pts (59.8yrs, 76.2%F, 28.1kg/m2) underwent corrective ASD surgery, with 1,053 pts in the non-HAC group and 118 in the HAC group. Of these pts, 25.4% had UTI, 15.4% DVT, 19.2% superficial SSI, 20.8% deep SSI, and 19.2% PE. HAC pts were on average older (63.5 vs 59.3, p=0.004) and more often frail (51.3vs39.7%,p=0.021)than non-HAC pts. Postop LOS and reoperation were most associated with HAC groups: [1] LOS>7 days [2] reoperation. Patient-related predictors of HACs were [3] age>50yr, [4] frailty, and [13] BMI>31. Procedure-related predictors of HACs were [5] operative-time >405mins, [6] levels fused >9, EBL>1450mL, and [11] decompression. BL radiographic predictors were [7] PT>20°,[9] PI-LL>6°, [10] TL Cobb angle>15°,[12] SVA C7-S1>29mm. No differences were observed between groups with regards to IHS ODI(0.73vs0.74,p=0.863), SRS(1.3vs1.3,p=0.374), NRS Back (0.6vs0.6,p=0.158). HAC had higher rates of reoperation than non-HAC (0.08 vs 0.01, p=0.066), and any HAC within 30-days of index was a significant predictor of reoperation (OR:2.448 [1.94-3.09],p<0.001). CONCLUSIONS:In a population of ASD patients, HACs were associated with length of stay, reoperation, age, and frailty. Radiographic parameters such as pelvic tilt>20°, PI-LL>6°, & SVA>29mm also increased odds of HACs, and should raise postoperative awareness for HAC development.

BACKGROUND CONTEXT: Preoperative opioid consumption, poor mental health, and lower socioeconomic status are each associated with worse surgical outcomes for adult spinal deformity (ASD). Little data exits evaluating preoperative morphine milligram equivalent (MME) consumption and preoperative mental health, social function, and socioeconomic status in ASD. PURPOSE: Evaluate the correlations between preoperative daily MME consumption and preoperative depression, anxiety, mental health scores, and socioeconomic status for ASD patients prior to receiving reconstructive ASD surgery. We hypothesized that preoperative MME consumption correlates with preoperative depression, anxiety, poor mental health, poor social function, and poor socioeconomic status in ASD. STUDY DESIGN/SETTING: Preoperative analysis of ASD patients prospectively enrolled into a multicenter study. PATIENT SAMPLE: ASD patients prospectively enrolled into multicenter study. OUTCOME MEASURES: Numeric rating scale (NRS) back and leg pain, Scoliosis Research Society-22r questionnaire (SRS-22r), Edmonton Frailty Index (EFI score), grip strength, Veterans Rand Health Questionnaire (VR-12), Oswestry Disability Index (ODI), daily morphine milligram equivalent consumption (MME), PROMIS-Pain Interference (PROMIS-PI), PROMIS-Physical Function (PROMIS-PF), PROMIS-Depression (DEP), PROMIS-Anxiety (ANX), PROMIS-Satisfaction with Social Roles (SR) and PROMIS-Satisfaction with Discretionary Social Activities (SDA) computer adaptive tests (CATs), Area Deprivation Index (ADI) scores.
METHOD(S): From 2018-2020, ASD patients were prospectively enrolled into a multicenter study. Preoperative MME was calculated. Preoperative PROMIS-DEP, PROMIS-ANX, PROMIS=SR, PROMIS-SDA, PROMIS-PI and PF, SRS-22r total and domain scores, and VR-12 mental component summary (MCS) were calculated. ADI scores were collected to assess socioeconomic status, as previously described. MME data were log transformed and two-tailed Pearson correlation coefficients calculated. Correlation strengths were interpreted according to Cohen. Confidence intervals were created with 1,000 sample bootstrapping.
RESULT(S): A total of 207/207 patients enrolled were evaluated; mean age 61 years (18-81). Preoperative opioid consumption was reported in 38% patients (n=78; mean preoperative MME 22.5 mg, range 1-420 mg). Preoperative MME did not correlate with PROMIS-ANX (p=0.07) and did not correlate with socioeconomic status (ADI; p=0.37). Preoperative MME showed small correlations with PROMIS-DEP (r=0.2, p=0.01), VR-12 MCS (r=-.2, p=0.002), and SRS-Mental Health (r=-0.2, p=0.005). Preoperative MME showed moderate correlations with PROMIS-PI (r=0.4, p<0.0001), PROMIS-PF (r=-0.4, p<0.0001), SRS-Pain (r=-0.5, p<0.0001), SRS-Function (r=-0.4, p<0.0001), PROMIS-SR (r=-0.3, p<0.0001) and PROMIS-SSA (r=-0.4, p<0.0001).
CONCLUSION(S): Prospective evaluation of 207 ASD patients demonstrated minimal to no correlations between preoperative MME consumption and preoperative anxiety, depression or low socioeconomic status. Preoperative MME consumption demonstrated moderate correlations with preoperative pain, physical function, and social function scores. The negative impacts of opioid consumption on physical measures are likely independent of psychosocial variables in ASD. FDA DEVICE/DRUG STATUS: This abstract does not discuss or include any applicable devices or drugs.
Copyright

BACKGROUND CONTEXT: Deterioration of global coronal alignment (GCA) may be associated with worse outcomes after adult spinal deformity (ASD) surgery. The impact of fusion length and upper instrumented vertebra (UIV) selection for patients with this complication is unclear. PURPOSE: Our objective was to compare outcomes for long sacropelvic fusions with upper-thoracic (UT) vs lower-thoracic (LT) UIV in patients with worsening GCA>=1cm. STUDY DESIGN/SETTING: Retrospective review of a prospectively collected multicenter case registry. PATIENT SAMPLE: Database enrollment required age >=18 years, scoliosis >=20degree, sagittal vertical axis (SVA) >=5cm, pelvic tilt >=25degree, or thoracic kyphosis >=60degree. OUTCOME MEASURES: Radiographic alignment, HRQL (Oswestry Disability Index [ODI], Short Form-36 [SF-36], Scoliosis Research Society-22 [SRS-22r], numerical rating scale [NRS] back/leg pain scores), and complications.
Method(s): This is a retrospective analysis of a prospective multicenter database of consecutive ASD patients. Index operations involved instrumented fusion from sacropelvis to thoracic spine. Global coronal deterioration was defined as worsening GCA>=1cm from preoperative to 2-year follow-up.
Result(s): Of 875 potentially eligible patients, 560 (64%) had complete 2-year follow-up data, of which 144 (25.7%) demonstrated worse GCA at 2-year postop (UT 35.4%, LT 64.6%). At baseline, UT had younger age (61.6+/-9.9 vs 64.5+/-8.6years, p=0.008), more osteoporosis (35.3% vs 16.1%, p=0.009), and worse scoliosis (51.9+/-22.5degree vs 32.5+/-16.3degree, p<0.001). Index operations were comparable except UT had longer fusions (16.4+/-0.9 vs 9.7+/-1.2 levels, p<0.001) and operative duration (8.6+/-3.2 vs 7.6+/-3.0hrs, p=0.023). At 2-year follow-up, global coronal deterioration averaged 2.7+/-1.4cm (1.9 to 4.6cm, p<0.001), scoliosis improved (39.3+/-20.8degree to 18.0+/-14.8degree, p<0.001), and sagittal spinopelvic alignment improved significantly for all patients. UT maintained smaller positive C7-sagittal vertical axis (SVA) (2.7+/-5.7 vs 4.7+/-5.7cm, p=0.014). Postoperative 2-year health-related quality-of-life (HRQL) was significantly improved from baseline for all patients. Significant HRQL comparisons included: UT had worse SRS-22r Activity (3.2+/-1.0 vs 3.6+/-0.8, p=0.040) and SRS-22r Satisfaction (3.9+/-1.1 vs 4.3+/-0.8, p=0.021). Also, fewer UT patients improved by >=1 minimal clinically important difference in leg pain NRS (41.3% vs 62.7%, p=0.020). Total reported complications (total=208, reoperation=53/major=77/minor=78) had comparable percentages of affected UT vs LT patients, but the percentage of re-operated patients was higher for UT (35.3% vs 18.3%, p=0.023). UT had higher reoperation rates for rod fracture (13.7% vs 2.2%, p=0.006), pseudarthrosis (7.8% vs 1.1%, p=0.006), but not proximal junctional kyphosis (9.8% vs 8.6%, p=0.810).
Conclusion(s): In ASD patients with worse 2-year GCA after long sacropelvic fusion, upper-thoracic UIV was associated with worse 2-year HRQL compared to lower-thoracic UIV. This may suggest residual global coronal malalignment is clinically less tolerated in ASD patients with longer fusions to proximal thoracic spine. These results can inform operative planning and improve patient counseling. FDA DEVICE/DRUG STATUS: This abstract does not discuss or include any applicable devices or drugs.
Copyright

BACKGROUND CONTEXT: ASD is a vague and heterogeneous label applied to adults afflicted with varying types, severities, and etiologies of spine deformities. We hypothesized that ASD patients with a history of spine fusion and associated spine deformity (revision=R) have distinct pathognomonic differences from ASD patients with no history of spine fusion (primary=P). PURPOSE: Evaluate baseline differences for revision vs primary ASD patients including demographics, radiographic spine deformity, functional measures, opiate consumption and patient-reported outcome measures (PROMs), prior to receiving reconstructive ASD surgery. STUDY DESIGN/SETTING: Preoperative analysis of ASD patients prospectively enrolled into a multicenter study. PATIENT SAMPLE: ASD patients prospectively enrolled into multicenter study. OUTCOME MEASURES: Numeric rating scale (NRS) back and leg pain, Scoliosis Research Society-22r questionnaire (SRS-22r), Edmonton Frailty Index (EFI score), grip strength, Veterans Rand Health Questionnaire (VR-12), Oswestry Disability Index (ODI), daily morphine milligram equivalent consumption (MME), PROMIS-Pain Interference (PROMIS-PI), PROMIS-Physical Function (PROMIS-PF), PROMIS-Depression (DEP), PROMIS-Anxiety (ANX), PROMIS-Satisfaction with Social Roles (SR) and PROMIS-Satisfaction with Discretionary Social Activities (SSA) computer adaptive tests (CATs).
METHOD(S): From 2018-2020, patients age >18 years were enrolled in a multicenter prospective study evaluating surgical treatment for ASD. Patients were dichotomized according to R vs P, and preop demographics, grip strength, frailty, daily MME consumption, physical examination, radiographic measures, and PROMs data were compared.
RESULT(S): A total of 204/204 enrolled patients were evaluated; R (n=99), P (n= 105). R and P had similar age, Charleson Comorbidity Index (CCI) and gender distribution (p>0.05). R had greater daily MME consumption (35mg vs 15mg), were more frail (EFI score 4 vs 2), and had greater incidence of motor deficits (54% vs 37%) than P, respectively (p<0.05). R differed radiographically from P in 11/15 measurements, as nearly all sagittal parameters were worse for R (SVA=139mm vs 57mm; PI-LL=26degree vs 12degree; PT= 28.2degree vs 20.7degree), while P had greater scoliosis (50.6degree vs 20.3degree), respectively (p<0.05). Nearly all PROM measures were worse for R vs P, including disability (ODI=48 vs 38), pain measures (PROMIS PI=66.9 vs 61.9; NRS-Back=7.0 vs 6.0), physical function (PROMIS-PF=32.8 vs 36.8, SRS-Activity=2.6 vs 3.2), social function (PROMIS-SSA= 40.4 vs 45.4), depression (PROMIS-DEP=51.1 vs 48.8), and self-image (SRS-Appearance=2.2 vs 2.6).
CONCLUSION(S): Revision ASD patients are distinctly different from primary ASD patients. Despite having similar preop age, gender and CCI, R were more frail, consumed more opiates, and reported greater pain, disability, function, and worse mental health than P. R had greater sagittal deformities while P had worse coronal deformities. Future analysis of ASD patients should distinguish between revision and primary patients to avoid confounding analyses. FDA DEVICE/DRUG STATUS: This abstract does not discuss or include any applicable devices or drugs.
Copyright

BACKGROUND CONTEXT: ASD surgery is associated with postoperative improvements in patient pain and function but is also associated with high complication rates and long recovery. Accordingly, if given a choice, patients may indicate they would not undergo surgery again. PURPOSE: At minimum two years postop, evaluate 1) surgically treated ASD patients for willingness to receive/not receive the same surgery, 2) surgeon willingness to perform/not perform the same surgery, 3) surgeon opinion if the corresponding patient would indicate they would/would not have the same surgery again. STUDY DESIGN/SETTING: Analysis of patient vs surgeon willingness to perform/receive surgery for ASD patients enrolled into a prospective, multicenter study. PATIENT SAMPLE: Surgically treated ASD patients prospectively enrolled into multicenter study. OUTCOME MEASURES: Numeric rating scale (NRS) back and leg pain, Scoliosis Research Society-22r questionnaire (SRS-22r), Short Form-36v2 questionnaire (SF-36), Oswestry Disability Index (ODI), estimated blood loss, duration of hospital stay, postoperative complications, revision spine surgery, patient and surgeon willingness to perform surgery.
Method(s): Surgically treated ASD patients, prospectively enrolled into a multicenter study from 2009-2018, were asked at minimum 2 years postop, using SRS-22r question 22 if, based upon their surgical and recovery experience, they would undergo the same surgery. Surgeons were matched to their corresponding patients and the surgeons asked if 1) surgeon would perform the same surgery on the patient and why/why not, 2) surgeon believed the patient would undergo the same surgery and why/why not. Patients were divided into those that indicated they would (yes) or not (no) have same surgery. Agreement between patient and surgeon willingness for same surgery was assessed and correlations between willingness for same surgery and postop complications, deformity improvement, and PROMs evaluated.
Result(s): Of 961 patients eligible for study, 580 were evaluated. The no group (n=108, 18.6%) had similar levels fused, osteotomies, duration of hospital and SICU stay, and major complications as the yes group. (n=472; 81.4%; p>0.05). No group members were younger (58.5 vs 61.6 years), more frail (ASD frailty scale 3.9 vs 3.3), and at minimum 2-years postop had more complications requiring surgery and worse postop improvements for all PROMs including ODI (3.8 vs 18.9), SF-36 PCS (1.8 vs 10) and SRS-22r total (0.4 vs 0.9), pain (0.5 vs 1.2), activity (0.2 vs0.7), and self-image (0.6 vs 1.3) than the yes group, respectively (p<0.05). MCID was reached in 28-56% of no group vs 62- 81% of yes group. Patient willingness to receive surgery varied by surgical institution (70% to 89%; p<0.05). Surgeons accurately identified yes group (91%) but poorly identified the no group (22%; p<0.05).
Conclusion(s): ASD patient willingness to undergo same surgery is important for counseling. Unwillingness for same surgery was associated with PROMs, MCID and complications requiring surgery. Surgeons were poorly able to identify patients unwilling to undergo the same surgery. More research is needed to understand patient experiences recovering from ASD surgeries. FDA DEVICE/DRUG STATUS: This abstract does not discuss or include any applicable devices or drugs.
Copyright

BACKGROUND CONTEXT: ASD is a complex pathology that benefits greatly from surgical treatment despite being associated with high rates of complications. Despite continuous innovation, little is known regarding the association between changes in surgical techniques and complications. PURPOSE: To investigate the evolution of patient profiles and surgical complications across a single prospective multicenter database. STUDY DESIGN/SETTING: Retrospective review of prospective data. PATIENT SAMPLE: This study included 947 adult spinal deformity patients surgically treated between 2008 and 2018. OUTCOME MEASURES: Complication types and rates.
METHOD(S): Surgical ASD patients (TK >60degree, SVA >5cm, PT >25degree or Cobb angle >20degree) with minimum 2-year follow-up were included and stratified into 3 equal groups by date of surgery. Demographic, preoperative data, surgical information, and complications were compared across time using a moving average of 316 patients to delineate those enrolled at the beginning of the study (Early) from the most recent one (Late).
RESULT(S): Among the total, 947/1260 (67%) patients completed their 2-year follow-up with an enrollment rate of 7.7+/-4.1 patients per month. Compared to the Early phase (Oct 2008 and Nov 2012), patients enrolled more recently (Jan 2016 to Jan 2018) were older (Age: 56.7+/-15yovs 64.3+/-12.3), sicker (CCI: 1.46+/-1.6 vs 2.08+/-1.78), more disabled (ODI: 42.6+/-19.4 vs 45.7+/-15.3; PCS: 32.8+/-10.4 vs 29.7+/-8.5), with more pronounced sagittal deformity (SRS-Schwab type N: 26.3% vs 50.9%: PI-LL modifier ++: 37.1% vs 46.8%) (all p<0.05). Changes in surgical treatment included an increase use of IBF (61% vs 69.9%), more ACR/3CO use (21% vs 37%) and a decrease in 3CO rate (21% vs 12%), shorter fusion (11.2+/-4 vs 9.8+/-5), more supplemental rods (0.3% vs 26.9%) and BMP use (64.1% vs 80.1%) (all p<0.05), but no significant difference in invasiveness (91.2+/-37.1 vs 86.0+/-36.9 p=0.06). LOS decrease by 1 day, EBL by 500 cc and rate of ICU stay decrease from 71% to 53% (all p <0.001). There was no significant difference in overall complication rate (73% vs 67.4% p=0.14) despite a significant decrease in major complications requiring a reoperation (27.6% vs17.4% p=0.002) driven by a decrease in implant (8.3% vs 4.1% p=0.032) and radiographic failures (12.7% vs 5.7% p=0.002). Rate of major operative complication decreased (11.8% vs 6.7% p=0.028) while rate of major radiographic complication increased (0.6% vs 5.7% p<0.001) leading to a stable rate of major complications without reoperation (28.3% vs 27.9% p=0.92). No significant difference in minor complication rate (38.7% vs 34.2% p=0.24) The moving average analysis revealed a steady decrease in major complications associated to a reoperation (from 28% to 17%). The lowest peak of major complications (21%) occurred between Feb 2014 and Oct 2016, and the lowest overall complication rate (62%) occurred between July 2014 and Feb 2017.
CONCLUSION(S): Despite an increase in patient complexity including older, more medical morbidities and larger deformities, complication rates did not increase and the rate of complications requiring surgery decreased over time. These findings likely reflect evolutions in practice improvement including use of supplemental rods, PJK prophylaxis, BMP use, and targeting age-appropriate deformity corrections. FDA DEVICE/DRUG STATUS: This abstract does not discuss or include any applicable devices or drugs.
Copyright